EUROPE EPILEPSY DEVICES MARKET 2022-2028

Lifesciences | Medical Devices & Consumables

EUROPE EPILEPSY DEVICES MARKET 2022-2028

Market by Device Type, Application, Detection and Prediction Device Type, End-user, and Country Outlook | Forecast 2022-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton’s report, the epilepsy devices market in Europe is expected to witness growth at a CAGR of 7.94% during the forecasting years 2022-2028.




Report scope can be customized per your requirements - Request Free Sample Report 

The countries studied in the region comprise:

•         The United Kingdom

•         Germany

•         France

•         Spain

•         Italy

•         Rest of Europe

Germany holds the majority of the shares in the region’s market. The increasing geriatric population prone to epilepsy, reimbursement framework, and technological advancement in therapeutic devices are estimated to support epilepsy monitoring device demand. Besides this, the developed healthcare infrastructure and research funds from the governments create numerous opportunities for manufacturers in the market. Therefore, as stated above, these factors are anticipated to majorly drive the epilepsy devices market over the forecast period.

In Germany, the foundation of the healthcare system is the specialists and general practitioners. Specialized hospital outpatient clinics like epilepsy centers offer high-level medical care to critically ill patients. For instance, the Epilepsy Center Frankfurt Rhine-Main conducts pre-surgical evaluations for drug-refractory epilepsy, offering inpatient care to over 50,000 people yearly. Additionally, a 5% year-on-year increase in injuries during accidents has elevated the risk of epilepsy seizures due to traumatic brain injury. Thus, the rise in epilepsy cases is anticipated to widen the epilepsy devices market’s scope.

Furthermore, brain trauma, alcohol abuse, and cerebrovascular disorders are major factors increasing epilepsy monitoring devices demand in France. Estimates indicate the prevalence of epilepsy has increased among the older generation, which is another factor contributing to the epilepsy devices market’s development.

Around 30-40% of the patients are refractory to medication, also known as intractable epilepsy. While respective or ablative is a beneficial procedure, it is not an option for various people due to neurologic risk. In this regard, responsive neurostimulation is a cortically-based stimulator activated by electrocorticography patterns. The market’s development is determined based on application, end-user, device type, and detection and prediction device type. The application segment is further categorized into responsive neurostimulation, accelerometer, vagus nerve stimulation, and deep brain stimulation.

The prominent companies in the given market include LivaNova Plc, Cadwell Industries Inc, Nihon Kohden Corporation, Medtronic Plc, and Natus Medical Incorporated.

LivaNova Plc is a global medical technology company providing products and therapies for the brain and heart. Its diverse portfolio includes therapeutic medication for advanced circulatory support, cardiopulmonary, drug-resistant epilepsy, and obstructive sleep apnea. The company serves clients across healthcare systems in multiple regions. LivaNova is headquartered in London, United Kingdom.

 

Key deliverables of the report:

      Market CAGR during the forecasting years 2022-2028

      Detailed data highlighting key insights, industry components, and market strategies


    Comprehensive information and estimation of the epilepsy devices market revenue growth in Europe and its influence on the parent market


      In-depth study of forthcoming trends in consumer behavioral patterns


      A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces


   A wide-ranging study of factors that will challenge the Europe epilepsy devices market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE EPILEPSY DEVICES MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE EPILEPSY DEVICES MARKET

2.2. KEY INSIGHTS

2.2.1. GROWING USE OF TELEMEDICINE SERVICES

2.2.2. INCREASE IN DRUG AND DEVICE TRIALS FOR EPILEPSY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. KEY BUYING IMPACT ANALYSIS

2.4.1. COMFORT & USABILITY

2.4.2. PRODUCT FEATURES

2.4.3. CONFIDENTIALITY

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. INDUSTRY COMPONENTS

2.8. REGULATORY FRAMEWORK

2.9. KEY MARKET STRATEGIES

2.9.1. DEVELOPMENTS & PRODUCT LAUNCHES

2.9.2. COLLABORATIONS

2.9.3. ACQUISITIONS

2.10. MARKET DRIVERS

2.10.1. COMBATING EPILEPSY THROUGH EARLY DETECTION AND DIAGNOSIS

2.10.2. RISING PREVALENCE OF EPILEPSY

2.11. MARKET CHALLENGES

2.11.1. UNAWARENESS ABOUT EPILEPSY AMONG THE GENERAL MASSES

2.11.2. LACK OF NEUROLOGY SPECIALISTS IN THE HEALTHCARE SYSTEM

2.12. MARKET OPPORTUNITIES

2.12.1. R&D ACTIVITIES DUE TO GROWING EPILEPSY CASES IN OLD PEOPLE

2.12.2. ASCENDING POST-TRAUMATIC EPILEPSY (PTE) CASES DUE TO BRAIN INJURIES

2.12.3. TECHNOLOGICAL ADVANCES IN NON-INVASIVE WEARABLE SENSORS

3. EUROPE EPILEPSY DEVICES MARKET OUTLOOK - BY DEVICE TYPE

3.1. TRADITIONAL DEVICES

3.2. WEARABLE DEVICES

3.2.1. WATCHES

3.2.2. BRACELETS

3.2.3. CAMERA DEVICES

3.2.4. MATTRESS DEVICES

3.2.5. ANTI-SUFFOCATION PILLOWS

3.2.6. OTHER WEARABLE DEVICES

3.3. IMPLANTABLE DEVICES

4. EUROPE EPILEPSY DEVICES MARKET OUTLOOK - BY APPLICATION

4.1. VAGUS NERVE STIMULATION

4.2. DEEP BRAIN STIMULATION

4.2.1. MOVEMENT DISORDERS

4.2.2. EPILEPSY

4.3. ACCELEROMETER

4.4. RESPONSIVE NEUROSTIMULATION

5. EUROPE EPILEPSY DEVICES MARKET OUTLOOK - BY DETECTION AND PREDICTION DEVICE TYPE

5.1. ELECTROENCEPHALOGRAM

5.2. INTRACRANIAL EEG

5.3. SURFACE ELECTROMYOGRAPHY

5.4. ELECTROCARDIOGRAPHY

5.5. VIDEO DETECTION SYSTEMS

5.6. ELECTRODERMAL ACTIVITY

5.7. IMPLANTED ADVISORY SYSTEMS

5.8. OTHER DETECTION AND PREDICTION DEVICE TYPES

6. EUROPE EPILEPSY DEVICES MARKET OUTLOOK - BY END-USER

6.1. HOSPITALS & CLINICS

6.2. NEUROLOGY CENTERS

6.3. HOMECARE SETTINGS

6.4. OTHER END-USERS

7. EUROPE EPILEPSY DEVICES MARKET – COUNTRY OUTLOOK

7.1. UNITED KINGDOM

7.2. GERMANY

7.3. FRANCE

7.4. ITALY

7.5. SPAIN

7.6. REST OF EUROPE

8. COMPETITIVE LANDSCAPE

8.1. LIVANOVA PLC

8.2. NATUS MEDICAL INCORPORATED

8.3. CADWELL INDUSTRIES INC

8.4. NIHON KOHDEN CORPORATION

8.5. COMPUMEDICS LIMITED

8.6. MEDTRONIC PLC

8.7. BOSTON SCIENTIFIC CORPORATION

8.8. EMPATICA INC

8.9. KONINKLIJKE PHILIPS NV

8.10. NEUROPACE INC

8.11. DRÄGERWERK AG & CO KGAA

8.12. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD

8.13. NEUROSOFT

9. RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.2. SOURCES OF DATA

9.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF COLLABORATIONS

TABLE 6: LIST OF ACQUISITIONS

TABLE 7: EXAMPLES OF ANTIEPILEPTIC DRUGS FOR THE ELDERLY AND THEIR ADVANTAGES

TABLE 8: EXAMPLE OF MOBILE EEG DEVICES

TABLE 9: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2022-2028 (IN $ MILLION)

TABLE 10: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)

TABLE 11: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)

TABLE 12: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)

TABLE 13: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2022-2028 (IN $ MILLION)

TABLE 14: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2022-2028 (IN $ MILLION)

TABLE 15: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

List of Figures

FIGURE 1: KEY BUYING IMPACT ANALYSIS

FIGURE 2: MARKET ATTRACTIVENESS INDEX

FIGURE 3: INDUSTRY COMPONENTS

FIGURE 4: EUROPE EPILEPSY DEVICES MARKET, BY DEVICE TYPE, 2021 & 2028 (IN %)

FIGURE 5: EUROPE EPILEPSY DEVICES MARKET, BY TRADITIONAL DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 6: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 7: EUROPE EPILEPSY DEVICES MARKET, BY WEARABLE DEVICES, 2021 & 2028 (IN %)

FIGURE 8: EUROPE EPILEPSY DEVICES MARKET, BY WATCHES, 2022-2028 (IN $ MILLION)

FIGURE 9: EUROPE EPILEPSY DEVICES MARKET, BY BRACELETS, 2022-2028 (IN $ MILLION)

FIGURE 10: EUROPE EPILEPSY DEVICES MARKET, BY CAMERA DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 11: EUROPE EPILEPSY DEVICES MARKET, BY MATTRESS DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 12: EUROPE EPILEPSY DEVICES MARKET, BY ANTI-SUFFOCATION PILLOWS, 2022-2028 (IN $ MILLION)

FIGURE 13: EUROPE EPILEPSY DEVICES MARKET, BY OTHER WEARABLE DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 14: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTABLE DEVICES, 2022-2028 (IN $ MILLION)

FIGURE 15: EUROPE EPILEPSY DEVICES MARKET, BY APPLICATION, 2021 & 2028 (IN %)

FIGURE 16: EUROPE EPILEPSY DEVICES MARKET, BY VAGUS NERVE STIMULATION, 2022-2028 (IN $ MILLION)

FIGURE 17: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2022-2028 (IN $ MILLION)

FIGURE 18: EUROPE EPILEPSY DEVICES MARKET, BY DEEP BRAIN STIMULATION, 2021 & 2028 (IN %)

FIGURE 19: EUROPE EPILEPSY DEVICES MARKET, BY MOVEMENT DISORDERS, 2022-2028 (IN $ MILLION)

FIGURE 20: EUROPE EPILEPSY DEVICES MARKET, BY EPILEPSY, 2022-2028 (IN $ MILLION)

FIGURE 21: EUROPE EPILEPSY DEVICES MARKET, BY ACCELEROMETER, 2022-2028 (IN $ MILLION)

FIGURE 22: EUROPE EPILEPSY DEVICES MARKET, BY RESPONSIVE NEUROSTIMULATION, 2022-2028 (IN $ MILLION)

FIGURE 23: EUROPE EPILEPSY DEVICES MARKET, BY DETECTION AND PREDICTION DEVICE TYPE, 2021 & 2028 (IN %)

FIGURE 24: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROENCEPHALOGRAM, 2022-2028 (IN $ MILLION)

FIGURE 25: EUROPE EPILEPSY DEVICES MARKET, BY INTRACRANIAL EEG, 2022-2028 (IN $ MILLION)

FIGURE 26: EUROPE EPILEPSY DEVICES MARKET, BY SURFACE ELECTROMYOGRAPHY, 2022-2028 (IN $ MILLION)

FIGURE 27: EUROPE EPILEPSY DEVICES MARKET, BY ELECTROCARDIOGRAPHY, 2022-2028 (IN $ MILLION)

FIGURE 28: EUROPE EPILEPSY DEVICES MARKET, BY VIDEO DETECTION SYSTEMS, 2022-2028 (IN $ MILLION)

FIGURE 29: EUROPE EPILEPSY DEVICES MARKET, BY ELECTRODERMAL ACTIVITY, 2022-2028 (IN $ MILLION)

FIGURE 30: EUROPE EPILEPSY DEVICES MARKET, BY IMPLANTED ADVISORY SYSTEMS, 2022-2028 (IN $ MILLION)

FIGURE 31: EUROPE EPILEPSY DEVICES MARKET, BY OTHER PREDICTION AND DETECTION DEVICE TYPES, 2022-2028 (IN $ MILLION)

FIGURE 32: EUROPE EPILEPSY DEVICES MARKET, BY END-USER, 2021 & 2028 (IN %)

FIGURE 33: EUROPE EPILEPSY DEVICES MARKET, BY HOSPITALS & CLINICS, 2022-2028 (IN $ MILLION)

FIGURE 34: EUROPE EPILEPSY DEVICES MARKET, BY NEUROLOGY CENTERS, 2022-2028 (IN $ MILLION)

FIGURE 35: EUROPE EPILEPSY DEVICES MARKET, BY HOMECARE SETTINGS, 2022-2028 (IN $ MILLION)

FIGURE 36: EUROPE EPILEPSY DEVICES MARKET, BY OTHER END-USERS, 2022-2028 (IN $ MILLION)

FIGURE 37: EUROPE EPILEPSY DEVICES MARKET, BY COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 38: UNITED KINGDOM EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 39: GERMANY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 40: FRANCE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 41: ITALY EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 42: SPAIN EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

FIGURE 43: REST OF EUROPE EPILEPSY DEVICES MARKET 2022-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying